Immunologic markers, vasculitis-associated autoantibodies, and complement levels in patients with COVID-19
Background: The cause of coronavirus disease 2019 (COVID-19) is a virus which can lead to severe acute respiratory syndrome-CoV-2 (SARS-COV-2). There are evidences of involvement of immune system in pathogenesis of this disease. We investigated the presence of various vasculitis-associated autoantib...
Main Authors: | Maryam Mobini, Roya Ghasemian, Laleh Vahedi Larijani, Maede Mataji, Iradj Maleki |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Journal of Research in Medical Sciences |
Subjects: | |
Online Access: | http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2021;volume=26;issue=1;spage=103;epage=103;aulast=Mobini |
Similar Items
-
Complement blockade in the management of antineutrophil cytoplasmic antibodyassociated vasculitis
by: José Salvador GarcÃa-Morillo, et al.
Published: (2022-10-01) -
Cutaneous Vasculitis and Recurrent Infection Caused by Deficiency in Complement Factor I
by: Sira Nanthapisal, et al.
Published: (2018-04-01) -
Profiling Complement System Components in Primary CNS Vasculitis
by: Milani Deb-Chatterji, et al.
Published: (2021-05-01) -
LUPUS VASCULITIS
by: Desislava Tsvetanova, et al.
Published: (2019-03-01) -
Rheumatic manifestations of hepatitis C virus infection are associated with autoantibodies but not viremia
by: Meng-Tzu Weng, et al.
Published: (2023-08-01)